Searchable abstracts of presentations at key conferences in endocrinology

ea0016p334 | Endocrine tumours | ECE2008

The cAMP analog 8CL-cAMP enhances PKA RIIb, triggers apoptosis and blocks cells at S and G2 cell cycle phases after 4 days of treatment in the human adrenocortical cells H295R.

Bouizar Zhor , Berterat Jerome , Rizk-Rabin Marthe

Various alterations of the cyclic AMP (cAMP) signalling cascade has been observed in adrenocortical tumors. Changes of the PKA regulatory subunits expression in tumors may positively or negatively regulate proliferation. 8CL-cAMP, a site selective cAMP analogue, induces growth inhibition in a variety of human cancer cell lines. The aim of the study was to determine if 8CL-cAMP acts on adrenocortical carcinoma H295R cell growth.We have determined the invo...

ea0016p311 | Endocrine tumours | ECE2008

Parathyroid-hormone related- Peptide and PTHrP receptor type 1 are expressed in human adrenocortical carcinoma and regulate cell proliferation and apoptosis in H295R an adrenocortical-derived cell line

Rizk-Rabin Marthe , Assie Guillaume , Fernande Fernande , Perlemoine Karine , Hamzaoui Hinda , Tissier Frederique , Lieberherr Michele , Bertagna Xavier , Bertherat Jeroome , Bouizar Zhor

Adrenocortical tumor (ACT) is a rare, heterogeneous malignancy whose pathogenesis is unclear. The oncoprotein PTHrP, found in many common tumors, can regulate their growth in an autocrine/paracrine fashion through the receptor PTH-R1. Little is known about the role of PTHrP in ACT. We monitored the synthesis of PTHrP and PTH-R1 in a series of 25 ACT: 12 adrenocortical carcinoma (ACC), 13 adrenocortical adenoma (ACA), and investigated the effects of PTHrP (1–34) on H295R c...